Company intelligence / Profile preview
Tivic Health Systems, Inc.
- Ownership
- Public · TIVC
- Employees
- ~7
- Development stage
- Commercial
Overview
ClearUP® Sinus Pain Relief is FDA-cleared and CE-marked as a handheld bioelectronic device to treat sinus pain/congestion. Clinical studies show efficacy in reducing symptoms of allergies/sinusitis. The company’s non-invasive cervical vagus nerve stimulation device has shown rapid effects on autonomic nervous system measures in early clinical studies. The lead biologic candidate Entolimod™ has completed late-stage development for acute radiation syndrome with prior government funding support.
- Therapeutic areas
- ImmunologyHematology
- Modalities
- DeviceBiologic
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Tivic Health Systems, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tivic Health Systems, Inc..